Electro-clinical and neurodevelopmental outcome in six children with early diagnosis of tuberous sclerosis complex and role of the genetic background
Authors:
Open Access
- 27 March 2020
- journal article
- research article
- Published by Springer Nature in Italian Journal of Pediatrics
- Vol. 46 (1) , 1-10
Abstract
Background: Seizures in individuals affected by tuberous sclerosis complex (TSC) commonly develop in the first year of life, are often preceded by a progressive deterioration of the electroencephalogram (EEG), and likely influence developmental outcome. Although early diagnosis of TSC has offered a tremendous opportunity to monitor affected patients before seizure onset, reports of the neurological manifestations of TSC in infants before seizure onset are still scarce. Here we describe early EEG activity, clinical and genetic data and developmental assessment in a group of TSC infants, with the aim of identifying possible prognostic factors for neurodevelopmental outcome. Methods: We report on six infants diagnosed with TSC pre- or perinatally, who underwent serial Video-EEG recordings during the first two years of life. EEGs were classified based on distribution and intensity of interictal epileptiform discharges, and Vigabatrin was introduced in case of ictal discharges. Psychomotor development, cognitive functioning and behavioral problems were assessed through standardized scales. Molecular testing included analysis for point mutations and deletions/duplications in TSC1 and TSC2. Results: EEG abnormalities appeared at a mean age of 4 months. Four of the six patients developed seizures. EEG abnormalities preceded the onset of clinical seizures in all of them. The two individuals with good seizure control showed normal development, while the other two exhibited psychomotor delays. The patients who did not develop seizures had normal development. A pathogenic variant in the TSC2 gene was detected in all patients but one. The one without a mutation identified did not develop seizures and showed normal neurodevelopment. Of note, the two patients presenting with the worst outcome (that is, poor seizure control and intellectual/behavioral disability) both carried pathogenic variants in the GAP domain of TSC2. Conclusion: Our report supports the importance of EEG monitoring before seizure onset in patients with TSC, and the correlation between prompt seizure control and positive neurodevelopmental outcome, regardless of seizure type. Our results also indicate a possible role of the genetic background in influencing the outcome.Keywords
This publication has 31 references indexed in Scilit:
- Influence of seizures on early development in tuberous sclerosis complexEpilepsy & Behavior, 2017
- Clinical Electroencephalographic Biomarker for Impending Epilepsy in Asymptomatic Tuberous Sclerosis Complex InfantsPediatric Neurology, 2016
- Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complexNeurobiology of Disease, 2015
- Use of mTOR Inhibitor Everolimus in Three Neonates for Treatment of Tumors Associated With Tuberous Sclerosis ComplexPediatric Neurology, 2015
- Epilepsy in TSC: Certain etiology does not mean certain prognosisEpilepsia, 2013
- Central TSC2 missense mutations are associated with a reduced risk of infantile spasmsEpilepsy Research, 2013
- The differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complexHuman Molecular Genetics, 2012
- Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complexEuropean Journal of Paediatric Neurology, 2011
- The natural history of epilepsy in tuberous sclerosis complexEpilepsia, 2010
- Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complexAnnals of Neurology, 2008